The pathway produces 3-hydroxy-octylamino benzoic acid, a metabolite increasing Foxp3 + Treg cell appearance in an NCOA7-dependent manner, contributing to an immunosuppressive tumor microenvironment [194]. The gene discussed is FOXP3; the disease is neoplasm.